Bangkok--23 May--Image Impact
Mr. Vitoon Vonghangool (2nd left), Managing Director of BioNet-Asia Co., Ltd. recently presided over the symposium on “SPEEDA ID regimen study result by The Queen Saovabha Memorial Institute and Safety and Immunogenicity result of JEVAC Clinical Study”, organized by Queen Saovabha Memorial Institute, The Thai Red Cross Society in co-operation with Liaoning Cheng Da Biotechnologh (CDBIO) of The Republic of China and Biovalys Co., Ltd.
Over 300 specialist and doctors from China and The Thai Red Cross participated at the two days symposium which was held at The Cholchan Pattaya Resort, Cholburi.
From left:
1. Mr. Mao Yu, Director International Business of Liaoning Chengda biotechnology, China
2. Mr. Vitoon Vonghangool, Managing Director of BioNet-Asia Co., Ltd.
3. Prof. Dr. Teerapong Tantawichien, Professor, Division of Infectious Diseases, Department of Medicine, Chulalongkorn University and King Chulalongkorn memorial Hospital, Thai Red Cross Society.
4. Assoc. Prof. Dr. Pornthep Chanthavanich, Staff, Department of Tropical Pediatrics.
5. Prof. Dr. Sumana Khomvilai, Deputy Director of Queen Saovabha Memorial Institute, The Thai Red Cross
6. Mr. Veerachai Tarnmaneewongse, Managing Director of Biovalys Co., Ltd.
7. Mr. Surapong Vonghangool, Senior Consultant of Biovalys Co., Ltd.
8. Mr. Wu Zhe, Product Manager of Liaoning Chengda biotechnology, China
คำค้น: Symposium on the result of safety and immunogenicity of vaccine